Download PDF
Pneumologie 2010; 64(8): 474-487
DOI: 10.1055/s-0029-1244120
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Infektionsdiagnostik in der Pneumologie

Teil 3: Nachweis von Viren und Pilzen aus dem Tracheobronchialsystem: Infektion oder Kolonisation?Diagnosis of Infections in PneumologyPart 3: Detection of Viral and Fungal Pathogens in the Tracheobronchial System: Infection or Colonisation?A.  Strassburg1 , K.  Dalhoff2 , I.  Engelmann3 , S.  Ewig4 , F.  J.  F.  Herth5 , J.  Knobloch6 , G.  Rohde7 , H.  Sahly8 , B.  Schaaf9 , C.  Lange1
  • 1Klinische Infektiologie, Medizinische Klinik, Forschungszentrum Borstel
  • 2Medizinische Klinik III, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • 3Institut für Virologie, Medizinische Hochschule Hannover; aktuelle Adresse: Centre d’Immunologie de Marseille-Luminy, Université de la Méditerranée, Marseille, France
  • 4Thoraxzentrum Ruhrgebiet, Kliniken für Pneumologie und Infektiologie, EVK Herne und Augusta-Kranken-Anstalt Bochum
  • 5Thoraxklinik am Universitätsklinikum Heidelberg, Pneumologie und Beatmungsmedizin
  • 6Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • 7Maastricht University Medical Centre (MUMC+), Department of Respiratory Medicine, Netherlands
  • 8Institut für Infektionsmedizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel, und IPM-Biotech, Labor Lademannbogen, Hamburg
  • 9Medizinische Klinik Nord, Pneumologie und Infektiologie, Klinikum Dortmund, Dortmund
Further Information

Publication History

eingereicht 12. 2. 2010

akzeptiert nach Revision 12. 3. 2010

Publication Date:
20 May 2010 (online)

Also available at
   Permissions and Reprints

Corrected by:

Infektionsdiagnostik in der PneumologiePneumologie 2010; 64(10): 631-631
DOI: 10.1055/s-0030-1255771

Zusammenfassung

Infektionen der unteren Atemwege und der Lungen sind im ambulanten und stationären Bereich der Krankenversorgung von herausragender Bedeutung. Im ersten Teil der Serie zur Infektionsdiagnostik in der Pneumologie wurden aktuelle Methoden der Infektionsdiagnostik bei Atemwegserkrankungen umfassend vorgestellt. Im zweiten Teil dieser Übersicht wurden Kriterien zur Unterscheidung von bakterieller Kolonisation und Infektion bei Atemwegsinfektionen behandelt. Im abschließenden dritten Teil wird diese klinisch bedeutsame Abgrenzung für humanpathogene Viren und Pilze vorgenommen. Die hier erläuterten diagnostischen Verfahren und Therapieindikationen können als wichtige Entscheidungshilfe im klinischen Alltag dienen.

Abstract

Lower respiratory tract infections play an important role in the ambulatory and hospital health-care sectors. State-of-the-art diagnoses of lower respiratory tract infections and methods to differentiate bacterial lower respiratory tract infections from colonisation have been described in the first two parts of this review series. The present article summarises current diagnostic methods and treatment indications for viral and fungal respiratory infections. These recommendations may guide clinicians in their decision to prescribe or withhold antibiotic therapies in daily clinical practice.

Literatur

  • 1 Lopez A D, Mathers C D, Ezzati M. et al . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.  Lancet. 2006;  367 1747-1757
    CrossrefPubMedGoogle Scholar
  • 2 Statistisches Bundesamt .Gestorbene: Deutschland, Jahre, Todesursachen.  Im Internet: www-genesis.destatis.de/genesis/onlineStand: 13.02.2010
    PubMedGoogle Scholar
  • 3 Beske F, Katalinic A, Peters E, Pritzkuleit R. Morbiditätsprognose 2050. Ausgewählte Krankheiten für Deutschland, Brandenburg und Schleswig-Holstein Schriftenreihe. Kiel; Fritz Beske Institut für Gesundheits-System-Forschung 2009
    PubMedGoogle Scholar
  • 4 Strassburg A, Rupp J, Herth F J. et al . [Infection diagnostics in pneumology. Part 1. Survey and methods].  Pneumologie. 2008;  62 730-743
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Strassburg A, Dalhoff K, Engelmann I. et al . [Diagnosis of Infection in Pneumology; Part II: Detection of Bacterial Microorganisms from the Tracheobronchial System: Infection or Colonisation?].  Pneumologie. 2010;  in press -0
    Google Scholar
  • 6 Modrow S, Falke D, Truyen U. Molekulare Virologie. 2 ed. Heidelberg – Berlin; Spektrum Akademischer Verlag 2003
    PubMedGoogle Scholar
  • 7 Denny Jr F W. The clinical impact of human respiratory virus infections.  Am J Respir Crit Care Med. 1995;  152 S4-12
    PubMedGoogle Scholar
  • 8 Rohde G, Wiethege A, Borg I. et al . Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.  Thorax. 2003;  58 37-42
    CrossrefPubMedGoogle Scholar
  • 9 Rohde G. Akute Tracheobronchitis.  Der Pneumologe. 2006;  3 12-19
    CrossrefPubMedGoogle Scholar
  • 10 Johnston S L, Pattemore P K, Sanderson G. et al . Community study of role of viral infections in exacerbations of asthma in 9 – 11 year old children.  BMJ. 1995;  310 1225-1229
    PubMedGoogle Scholar
  • 11 de Roux A, Marcos M A, Garcia E. et al . Viral community-acquired pneumonia in nonimmunocompromised adults.  Chest. 2004;  125 1343-1351
    CrossrefPubMedGoogle Scholar
  • 12 Rohde G, Drosten C, Borg I. et al . [Detection of respiratory viruses – how, when, where and why?].  Pneumologie. 2009;  63 14-22
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Seemungal T, Harper-Owen R, Bhowmik A. et al . Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2001;  164 1618-1623
    CrossrefPubMedGoogle Scholar
  • 14 Borg I, Rohde G, Loseke S. et al . Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases.  Eur Respir J. 2003;  21 944-951
    CrossrefPubMedGoogle Scholar
  • 15 Rohde G, Wiethege A, Borg I. et al . Influenza A virus in exacerbation of chronic obstructive pulmonary disease.  Eur Respir J. 2001;  18 (Suppl. 33) 152s
    PubMedGoogle Scholar
  • 16 Rohde G. Therapeutic targets in respiratory viral infections.  Curr Med Chem. 2007;  14 2776-2782
    CrossrefPubMedGoogle Scholar
  • 17 Mackie P L. The classification of viruses infecting the respiratory tract.  Paediatric respiratory reviews. 2003;  4 84-90
    CrossrefPubMedGoogle Scholar
  • 18 Gärtner B, Müller-Lantsch N. Herpesviren: Humane Herpesviren 6 – 8, EBV. Stuttgart, New York; Georg Thieme Verlag 2002
    PubMedGoogle Scholar
  • 19 Pellett P, Tipples G, Murray P. Human Herpesvirus 6, 7 and 8. Manual of Clinical Microbiology. Washington, D.C; ASM press 2003
    PubMedGoogle Scholar
  • 20 Arvin A M. Varicella-Zoster Virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3 ed. Philadelphia; Lippincott-Raven Publishers 1996: 2547-2585
    PubMedGoogle Scholar
  • 21 Whitley R J, Roizman B. Herpes simplex virus infections.  Lancet. 2001;  357 1513-1518
    CrossrefPubMedGoogle Scholar
  • 22 Britt W J, Alford C A. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3 ed. Philadelphia; Lippincott-Raven Publishers 1996: 2493-2523
    PubMedGoogle Scholar
  • 23 Luyt C E, Combes A, Deback C. et al . Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.  American journal of respiratory and critical care medicine. 2007;  175 935-942
    CrossrefPubMedGoogle Scholar
  • 24 Simoons-Smit A M, Kraan E M, Beishuizen A. et al . Herpes simplex virus type 1 and respiratory disease in critically-ill patients: Real pathogen or innocent bystander?.  Clin Microbiol Infect. 2006;  12 1050-1059
    CrossrefPubMedGoogle Scholar
  • 25 De Vos N, Van Hoovels L, Vankeerberghen A. et al . Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: a prospective study.  Clin Microbiol Infect. 2009;  15 358-363
    CrossrefPubMedGoogle Scholar
  • 26 Linssen C F, Jacobs J A, Stelma F F. et al . Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients.  Intensive Care Med. 2008;  34 2202-2209
    CrossrefPubMedGoogle Scholar
  • 27 Soldatou A, Davies E G. Respiratory virus infections in the immunocompromised host.  Paediatric respiratory reviews. 2003;  4 193-204
    CrossrefPubMedGoogle Scholar
  • 28 Feldman S. Varicella-Zoster virus pneumonitis.  Chest. 1994;  106 22-27
    PubMedGoogle Scholar
  • 29 Engelmann I, Gottlieb J, Meier A. et al . Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigation.  Critical care (London, England). 2007;  11 R119
    CrossrefPubMedGoogle Scholar
  • 30 van den Brink J W, Simoons-Smit A M, Beishuizen A. et al . Respiratory herpes simplex virus type 1 infection/colonisation in the critically ill: marker or mediator?.  J Clin Virol. 2004;  30 68-72
    CrossrefPubMedGoogle Scholar
  • 31 Kesson A M. Respiratory virus infections.  Paediatric respiratory reviews. 2007;  8 240-248
    CrossrefPubMedGoogle Scholar
  • 32 Stranska R, Schuurman R, de Vos M, van Loon A M. Routine use of a highly automated and internally controlled real-time PCR assay for the diagnosis of herpes simplex and varicella-zoster virus infections.  J Clin Virol. 2004;  30 39-44
    CrossrefPubMedGoogle Scholar
  • 33 Stephan F, Fajac A, Grenet D. et al . Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients.  Transplantation. 1997;  63 1430-1435
    CrossrefPubMedGoogle Scholar
  • 34 Buffone G J, Frost A, Samo T. et al . The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria.  Transplantation. 1993;  56 342-347
    CrossrefPubMedGoogle Scholar
  • 35 Weinberg A, Hodges T N, Li S. et al . Comparison of PCR, Antigenemia Assay, and Rapid Blood Culture for Detection and Prevention of Cytomegalovirus Disease after Lung Transplantation.  J Clin Microbiol. 2000;  38 768-772
    PubMedGoogle Scholar
  • 36 Engelmann I, Petzold D R, Kosinska A. et al . Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.  J Med Virol. 2008;  80 467-477
    CrossrefPubMedGoogle Scholar
  • 37 Eing B R, Baumeister H G, Kuehn J E, May G. Long-term persistence of immunoglobulin A (IgA) and IgM antibodies against human cytomegalovirus in solid-organ transplant recipients.  Clin Diagn Lab Immunol. 1999;  6 621-623
    PubMedGoogle Scholar
  • 38 Ison M G, Fishman J A. Cytomegalovirus pneumonia in transplant recipients.  Clinics in chest medicine. 2005;  26 691-705, viii
    CrossrefPubMedGoogle Scholar
  • 39 Tong C Y, Cuevas L, Williams H, Bakran A. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.  J Clin Microbiol. 1998;  36 2681-2685
    PubMedGoogle Scholar
  • 40 Hatherley L I, Hayes K, Jack I. Herpes virus in an obstetric hospital. II: Asymptomatic virus excretion in staff members.  Med J Aust. 1980;  2 273-275
    PubMedGoogle Scholar
  • 41 Hodinka R L. Human Cytomegalovirus. In: Murray PR, ed. Manual of clinical microbiology. 8 ed. Washington; ASM Press 2003: 1304-1318
    PubMedGoogle Scholar
  • 42 Bruynseels P, Jorens P G, Demey H E. et al . Herpes simplex virus in the respiratory tract of critical care patients: a prospective study.  Lancet. 2003;  362 1536-1541
    CrossrefPubMedGoogle Scholar
  • 43 Gooskens J, Templeton K E, Claas E C. et al . Quantitative detection of herpes simplex virus DNA in the lower respiratory tract.  J Med Virol. 2007;  79 597-604
    CrossrefPubMedGoogle Scholar
  • 44 Bewig B, Haacke T C, Tiroke A. et al . Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells.  Respiration. 2000;  67 166-172
    CrossrefPubMedGoogle Scholar
  • 45 Westall G P, Michaelides A, Williams T J. et al . Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.  The Journal of infectious diseases. 2004;  190 1076-1083
    CrossrefPubMedGoogle Scholar
  • 46 Chemaly R F, Yen-Lieberman B, Chapman J. et al . Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients.  Am J Transplant. 2005;  5 544-548
    CrossrefPubMedGoogle Scholar
  • 47 Bauer C C, Jaksch P, Aberle S W. et al . Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.  Journal of clinical microbiology. 2007;  45 324-328
    CrossrefPubMedGoogle Scholar
  • 48 Zedtwitz-Liebenstein K, Jaksch P, Bauer C. et al . Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients.  Transplantation. 2004;  77 1897-1899
    CrossrefPubMedGoogle Scholar
  • 49 Gershon A A, LaRussa P, Steinberg A P. Varicella-Zoster Virus. In: Murray PR, ed. Manual of clinical microbiology. 8 ed. Washington; ASM Press 2003: 1319-1330
    PubMedGoogle Scholar
  • 50 Rhodes J C. Aspergillus fumigatus: growth and virulence.  Med Mycol. 2006;  44 (Suppl. 1) S77-81
    CrossrefPubMedGoogle Scholar
  • 51 Summerbell R C, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi.  Mycopathologia. 1989;  106 13-22
    CrossrefPubMedGoogle Scholar
  • 52 Segal B H. Mouldy oldy: how fungus lives among us.  Blood. 2005;  105 2239
    CrossrefPubMedGoogle Scholar
  • 53 Stanzani M, Orciuolo E, Lewis R. et al . Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.  Blood. 2005;  105 2258-2265
    CrossrefPubMedGoogle Scholar
  • 54 Segal B H, Walsh T J. Current approaches to diagnosis and treatment of invasive aspergillosis.  Am J Respir Crit Care Med. 2006;  173 707-717
    CrossrefPubMedGoogle Scholar
  • 55 Karp J E, Burch P A, Merz W G. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis.  Am J Med. 1988;  85 203-206
    CrossrefPubMedGoogle Scholar
  • 56 Denning D W, Stevens D A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.  Rev Infect Dis. 1990;  12 1147-1201
    CrossrefPubMedGoogle Scholar
  • 57 Garcia-Vidal C, Upton A, Kirby K A, Marr K A. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation.  Clin Infect Dis. 2008;  47 1041-1050
    CrossrefPubMedGoogle Scholar
  • 58 Siddiqui S, Anderson V L, Hilligoss D M. et al . Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.  Clin Infect Dis. 2007;  45 673-681
    CrossrefPubMedGoogle Scholar
  • 59 Almyroudis N G, Holland S M, Segal B H. Invasive aspergillosis in primary immunodeficiencies.  Med Mycol. 2005;  43 (Suppl. 1) S247-259
    CrossrefPubMedGoogle Scholar
  • 60 Schwartz S, Thiel E. Clinical presentation of invasive aspergillosis.  Mycoses. 1997;  40 (Suppl. 2) 21-24
    CrossrefPubMedGoogle Scholar
  • 61 Hachem R, Sumoza D, Hanna H. et al . Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised?.  Cancer. 2006;  106 1581-1586
    CrossrefPubMedGoogle Scholar
  • 62 Greene R E, Schlamm H T, Oestmann J W. et al . Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.  Clin Infect Dis. 2007;  44 373-379
    CrossrefPubMedGoogle Scholar
  • 63 Kato T, Usami I, Morita H. et al . Chronic necrotizing pulmonary aspergillosis in pneumoconiosis: clinical and radiologic findings in 10 patients.  Chest. 2002;  121 118-127
    CrossrefPubMedGoogle Scholar
  • 64 Denning D W, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review.  Clin Infect Dis. 2003;  37 (Suppl. 3) S265-280
    CrossrefPubMedGoogle Scholar
  • 65 Kadakal F, Uysal M A, Ozgul M A. et al . A case report of endobronchial semi-invasive aspergillosis.  Tuberk Toraks. 2004;  52 179-182
    PubMedGoogle Scholar
  • 66 Soubani A O, Chandrasekar P H. The clinical spectrum of pulmonary aspergillosis.  Chest. 2002;  121 1988-1999
    CrossrefPubMedGoogle Scholar
  • 67 Freyschmidt J. Handbuch diagnostische Radiologie: Thorax. Bandherausgeber: Galanski M. Berlin, Heidelberg, New York; Springer-Verlag 2003
    PubMedGoogle Scholar
  • 68 Walsh T J, Anaissie E J, Denning D W. et al . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.  Clin Infect Dis. 2008;  46 327-360
    CrossrefPubMedGoogle Scholar
  • 69 Stevens D A, Moss R B, Kurup V P. et al . Allergic bronchopulmonary aspergillosis in cystic fibrosis–state of the art: Cystic Fibrosis Foundation Consensus Conference.  Clin Infect Dis. 2003;  37 (Suppl. 3) S225-264
    CrossrefPubMedGoogle Scholar
  • 70 Greenberger P A, Miller T P, Roberts M, Smith L L. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis.  Ann Allergy. 1993;  70 333-338
    PubMedGoogle Scholar
  • 71 Lake F R, Tribe A E, McAleer R. et al . Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus.  Thorax. 1990;  45 489-491
    CrossrefPubMedGoogle Scholar
  • 72 Tillie-Leblond I, Tonnel A B. Allergic bronchopulmonary aspergillosis.  Allergy. 2005;  60 1004-1013
    CrossrefPubMedGoogle Scholar
  • 73 Agarwal R. Allergic bronchopulmonary aspergillosis.  Chest. 2009;  135 805-826
    CrossrefPubMedGoogle Scholar
  • 74 Kradin R L, Mark E J. The pathology of pulmonary disorders due to Aspergillus spp.  Arch Pathol Lab Med. 2008;  132 606-614
    PubMedGoogle Scholar
  • 75 Morell F, Roger A, Cruz M J. et al . Suberosis: clinical study and new etiologic agents in a series of eight patients.  Chest. 2003;  124 1145-1152
    CrossrefPubMedGoogle Scholar
  • 76 Hamaguchi R, Saito H, Kegasawa K. et al . [A case of hypersensitivity pneumonitis resulting from inhalation of Aspergillus niger in a greenhouse worker who raised roses].  Nihon Kokyuki Gakkai Zasshi. 2009;  47 205-211
    PubMedGoogle Scholar
  • 77 Yoshida K, Ueda A, Yamasaki H. et al . Hypersensitivity pneumonitis resulting from Aspergillus fumigatus in a greenhouse.  Arch Environ Health. 1993;  48 260-262
    CrossrefPubMedGoogle Scholar
  • 78 Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.  Eur Respir J. 2007;  30 782-800
    CrossrefPubMedGoogle Scholar
  • 79 Segal B H, Walsh T J. Current approaches to diagnosis and treatment of invasive aspergillosis.  Am J Respir Crit Care Med. 2006;  173 707-717
    CrossrefPubMedGoogle Scholar
  • 80 Pfeiffer C D, Fine J P, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.  Clin Infect Dis. 2006;  42 1417-1427
    CrossrefPubMedGoogle Scholar
  • 81 Rex J H. Galactomannan and the diagnosis of invasive aspergillosis.  Clin Infect Dis. 2006;  42 1428-1430
    CrossrefPubMedGoogle Scholar
  • 82 Walsh T J, Shoham S, Petraitiene R. et al . Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.  J Clin Microbiol. 2004;  42 4744-4748
    CrossrefPubMedGoogle Scholar
  • 83 Mattei D, Rapezzi D, Mordini N. et al . False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.  J Clin Microbiol. 2004;  42 5362-5363
    CrossrefPubMedGoogle Scholar
  • 84 Mennink-Kersten M A, Warris A, Verweij P E. 1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.  N Engl J Med. 2006;  354 2834-2835
    CrossrefPubMedGoogle Scholar
  • 85 Musher B, Fredricks D, Leisenring W. et al . Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.  J Clin Microbiol. 2004;  42 5517-5522
    CrossrefPubMedGoogle Scholar
  • 86 Becker M J, Lugtenburg E J, Cornelissen J J. et al . Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.  Br J Haematol. 2003;  121 448-457
    CrossrefPubMedGoogle Scholar
  • 87 Meersseman W, Lagrou K, Maertens J. et al . Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.  Am J Respir Crit Care Med. 2008;  177 27-34
    CrossrefPubMedGoogle Scholar
  • 88 Pickering J W, Sant H W, Bowles C A. et al . Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.  J Clin Microbiol. 2005;  43 5957-5962
    CrossrefPubMedGoogle Scholar
  • 89 Senn L, Robinson J O, Schmidt S. et al . 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.  Clin Infect Dis. 2008;  46 878-885
    CrossrefPubMedGoogle Scholar
  • 90 Odabasi Z, Mattiuzzi G, Estey E. et al . Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.  Clin Infect Dis. 2004;  39 199-205
    CrossrefPubMedGoogle Scholar
  • 91 Ostrosky-Zeichner L, Alexander B D, Kett D H. et al . Multicenter clinical evaluation of the (1–>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.  Clin Infect Dis. 2005;  41 654-659
    CrossrefPubMedGoogle Scholar
  • 92 De Pauw B, Walsh T J, Donnelly J P. et al . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.  Clin Infect Dis. 2008;  46 1813-1821
    CrossrefPubMedGoogle Scholar
  • 93 Kumar A, Roberts D, Wood K E. et al . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.  Crit Care Med. 2006;  34 1589-1596
    CrossrefPubMedGoogle Scholar
  • 94 Petri M G, Konig J, Moecke H P. et al . Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.  Intensive Care Med. 1997;  23 317-325
    CrossrefPubMedGoogle Scholar
  • 95 Meersseman W, Lagrou K, Spriet I. et al . Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.  Intensive Care Med. 2009;  35 1526-1531
    CrossrefPubMedGoogle Scholar
  • 96 Worthington M. Fatal candida pneumonia in a non-immunosuppressed host.  J Infect. 1983;  7 159-161
    CrossrefPubMedGoogle Scholar
  • 97 Grossi P, Farina C, Fiocchi R, Dalla G asperina. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients.  Transplantation. 2000;  70 112-116
    PubMedGoogle Scholar
  • 98 Pappas P G, Rex J H, Sobel J D. et al . Guidelines for treatment of candidiasis.  Clin Infect Dis. 2004;  38 161-189
    CrossrefPubMedGoogle Scholar
  • 99 Azoulay E, Timsit J F, Tafflet M. et al . Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia.  Chest. 2006;  129 110-117
    CrossrefPubMedGoogle Scholar
  • 100 Haron E, Vartivarian S, Anaissie E. et al . Primary Candida pneumonia. Experience at a large cancer center and review of the literature.  Medicine (Baltimore). 1993;  72 137-142
    PubMedGoogle Scholar
  • 101 Kollef M H, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.  Chest. 1998;  113 412-420
    CrossrefPubMedGoogle Scholar
  • 102 Luna C M, Vujacich P, Niederman M S. et al . Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.  Chest. 1997;  111 676-685
    CrossrefPubMedGoogle Scholar
  • 103 el-Ebiary M, Torres A, Fabregas N. et al . Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study.  Am J Respir Crit Care Med. 1997;  156 583-590
    CrossrefPubMedGoogle Scholar
  • 104 Rello J, Esandi M E, Diaz E. et al . The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients.  Chest. 1998;  114 146-149
    CrossrefPubMedGoogle Scholar
  • 105 Wood G C, Mueller E W, Croce M A. et al . Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients.  Intensive Care Med. 2006;  32 599-603
    CrossrefPubMedGoogle Scholar
  • 106 Pittet D, Monod M, Suter P M. et al . Candida colonization and subsequent infections in critically ill surgical patients.  Ann Surg. 1994;  220 751-758
    CrossrefPubMedGoogle Scholar
  • 107 Ibanez-Nolla J, Nolla-Salas M, Leon M A. et al . Early diagnosis of candidiasis in non-neutropenic critically ill patients.  J Infect. 2004;  48 181-192
    CrossrefPubMedGoogle Scholar
  • 108 Hogan D A, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors.  Science. 2002;  296 2229-2232
    CrossrefPubMedGoogle Scholar
  • 109 Nseir S, Jozefowicz E, Cavestri B. et al . Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study.  Intensive Care Med. 2007;  33 137-142
    CrossrefPubMedGoogle Scholar
  • 110 Stringer J R, Beard C B, Miller R F. Spelling Pneumocystis jirovecii.  Emerg Infect Dis. 2009;  15 506
    PubMedGoogle Scholar
  • 111 Stringer J R, Beard C B, Miller R F, Wakefield A E. A new name (Pneumocystis jiroveci) for Pneumocystis from humans.  Emerg Infect Dis. 2002;  8 891-896
    CrossrefPubMedGoogle Scholar
  • 112 Kovacs J A, Hiemenz J W, Macher A M. et al . Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.  Ann Intern Med. 1984;  100 663-671
    CrossrefPubMedGoogle Scholar
  • 113 Baughman R P, Dohn M N, Frame P T. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients.  Am J Med. 1994;  97 515-522
    CrossrefPubMedGoogle Scholar
  • 114 Cadranel J, Gillet-Juvin K, Antoine M. et al . Site-directed bronchoalveolar lavage and transbronchial biopsy in HIV-infected patients with pneumonia.  Am J Respir Crit Care Med. 1995;  152 1103-1106
    PubMedGoogle Scholar
  • 115 Riebold D, Löbermann M, Reisinger E C. Diagnostic features and resistance testing of Pneumocystis jirovecii.  J Lab Med. 2008;  32 35-39
    CrossrefPubMedGoogle Scholar
  • 116 Morris A, Netravali M, Kling H M. et al . Relationship of pneumocystis antibody response to severity of chronic obstructive pulmonary disease.  Clin Infect Dis. 2008;  47 e64-68
    CrossrefPubMedGoogle Scholar
  • 117 Skelly M J, Holzman R S, Merali S. S-adenosylmethionine levels in the diagnosis of Pneumocystis carinii pneumonia in patients with HIV infection.  Clin Infect Dis. 2008;  46 467-471
    CrossrefPubMedGoogle Scholar
  • 118 Gupta R, Mirdha B R, Guleria R. et al . Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens.  Diagn Microbiol Infect Dis. 2009;  64 381-388
    CrossrefPubMedGoogle Scholar
  • 119 Huang L, Morris A, Limper A H, Beck J M. An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP).  Proc Am Thorac Soc. 2006;  3 655-664
    CrossrefPubMedGoogle Scholar
  • 120 Larsen H H, Kovacs J A, Stock F. et al . Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii.  J Clin Microbiol. 2002;  40 2989-2993
    CrossrefPubMedGoogle Scholar
  • 121 Morris A, Lundgren J D, Masur H. et al . Current epidemiology of Pneumocystis pneumonia.  Emerg Infect Dis. 2004;  10 1713-1720
    CrossrefPubMedGoogle Scholar
  • 122 Morris A, Kingsley L A, Groner G. et al . Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men.  AIDS. 2004;  18 793-798
    CrossrefPubMedGoogle Scholar
  • 123 Leigh T R, Kangro H O, Gazzard B G. et al . DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms.  Respir Med. 1993;  87 525-529
    CrossrefPubMedGoogle Scholar
  • 124 Huang L, Crothers K, Morris A. et al . Pneumocystis colonization in HIV-infected patients.  J Eukaryot Microbiol. 2003;  50 (Suppl.) 616-617
    CrossrefPubMedGoogle Scholar
  • 125 Wakefield A E, Lindley A R, Ambrose H E. et al . Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients.  J Infect Dis. 2003;  187 901-908
    CrossrefPubMedGoogle Scholar
  • 126 Wakefield A E, Pixley F J, Banerji S. et al . Detection of Pneumocystis carinii with DNA amplification.  Lancet. 1990;  336 451-453
    CrossrefPubMedGoogle Scholar
  • 127 Nevez G, Magois E, Duwat H. et al . Apparent absence of Pneumocystis jirovecii in healthy subjects.  Clin Infect Dis. 2006;  42 e99-101
    CrossrefPubMedGoogle Scholar
  • 128 Beard C B, Fox M R, Lawrence G G. et al . Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications.  J Infect Dis. 2005;  192 1815-1818
    CrossrefPubMedGoogle Scholar
  • 129 Nevez G, Guyot K, Totet A. et al . Pulmonary colonisation with Pneumocystis carinii in an immunosuppressed HIV-negative patient: detection and typing of the fungus by PCR.  J Med Microbiol. 2001;  50 198-200
    PubMedGoogle Scholar
  • 130 Sing A, Geiger A M, Hogardt M, Heesemann J. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR.  J Clin Microbiol. 2001;  39 2717-2718
    CrossrefPubMedGoogle Scholar
  • 131 Sing A, Roggenkamp A, Autenrieth I B, Heesemann J. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR.  J Clin Microbiol. 1999;  37 3409-3410
    PubMedGoogle Scholar
  • 132 Calderon E J, Regordan C, Medrano F J. et al . Pneumocystis carinii infection in patients with chronic bronchial disease.  Lancet. 1996;  347 977
    PubMedGoogle Scholar
  • 133 Morris A, Sciurba F C, Lebedeva I P. et al . Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization.  Am J Respir Crit Care Med. 2004;  170 408-413
    CrossrefPubMedGoogle Scholar
  • 134 Probst M, Ries H, Schmidt-Wieland T, Serr A. Detection of Pneumocystis carinii DNA in patients with chronic lung diseases.  Eur J Clin Microbiol Infect Dis. 2000;  19 644-645
    CrossrefPubMedGoogle Scholar
  • 135 Morris A, Sciurba F C, Norris K A. Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease?.  COPD. 2008;  5 43-51
    CrossrefPubMedGoogle Scholar

Bisher erschienene Beiträge dieser Serie

Prof. Dr. med. Dipl.-Biol. Christoph Lange

Klinische Infektiologie
Medizinische Klinik
Forschungszentrum Borstel

Parkallee 35
23845 Borstel

Email: clange@fz-borstel.de

      >